Feasibility of apparent diffusion coefficient in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids – a comparison with the Funaki classification

References

• Stewart EA, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110:279–287.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol. 2007;14(5):616–621.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
   PubMed Web of Science ®Google Scholar
• Al Hilli M, Stewart E. Magnetic resonance-guided focused ultrasound surgery. Semin Reprod Med. 2010;28(3):242–249.
   PubMed Web of Science ®Google Scholar
• Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging–guided focused ultrasound surgery—results of different treatment protocols 1. Radiology. 2007;243(3):885–893.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm C, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328.
   PubMed Web of Science ®Google Scholar
• Swe TT, et al. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics. Radiat Med. 1992;10:235–242.
   PubMedGoogle Scholar
• Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189(3):721–725.
   PubMed Web of Science ®Google Scholar
• Oguchi O, Mori A, Kobayashi Y, et al. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Obstet Gynaecol. 1995;21(2):107–117.
   PubMedGoogle Scholar
• Funaki K, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196:1–6.
   PubMed Web of Science ®Google Scholar
• Kim Y-S, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol. 2011;46:639–647.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Kim J-H, Rhim H, et al. High-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids : initial clinical outcomes. Radiology. 2012;263(2):600–609.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Kim B-G, Rhim H, et al. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation. Radiology. 2014;273(2):462–471.
   PubMed Web of Science ®Google Scholar
• Wei C, et al. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids. Abdom Radiol. 2017;43(8):2169–2175.
   Web of Science ®Google Scholar
• Hocquelet A, Denis de Senneville B, Frulio N, et al. Magnetic resonance texture parameters are associated with ablation efficiency in MR-guided high-intensity focussed ultrasound treatment of uterine fibroids. Int J Hyperthermia. 2017;33(2):142–149.
   PubMed Web of Science ®Google Scholar
• Kele PG, van der Jagt EJ. Diffusion weighted imaging in the liver. World J Gastroenterol. 2010;16(13):1567–1576.
   PubMed Web of Science ®Google Scholar
• Morani AC, Elsayes KM, Liu PS, et al. Abdominal applications of diffusion-weighted magnetic resonance imaging: where do we stand. World J Radiol. 2013;5(3):68–80.
   PubMedGoogle Scholar
• Feuerlein S, Pauls S, Juchems MS, et al. Pitfalls in abdominal diffusion-weighted imaging: how predictive is restricted water diffusion for malignancy. AJR Am J Roentgenol. 2009;193(4):1070–1076.
   PubMed Web of Science ®Google Scholar
• Sainio T, Komar G, Saunavaara J, et al. Wedged gel pad for bowel manipulation during MR-guided high-intensity focused ultrasound therapy to treat uterine fibroids: a case report. J Ther Ultrasound. 2018;6:10.
   PubMedGoogle Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol. 1984;10(6):787–800.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Keserci B, Partanen A, et al. Volumetric MR-HIFU ablation of uterine fibroids: role of treatment cell size in the improvement of energy efficiency. Eur J Radiol. 2012;81(11):3652–3659.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Lee J-W, Choi CH, et al. Uterine fibroids: correlation of T2 signal intensity with semiquantitative perfusion MR parameters in patients screened for MR-guided high-intensity focused ultrasound ablation. Radiology. 2016;278(3):925–935.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Trillaud H, Rhim H, et al. MR thermometry analysis of sonication accuracy and safety margin of volumetric MR imaging-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Radiology. 2012;265(2):627–637.
   PubMed Web of Science ®Google Scholar
• Kyriakou A. Multi-physics computational modeling of focused ultrasound therapies [dissertation]. Komotini (Greece): Democritus University of Thrace; 2015.
   Google Scholar
• Verma PK, Humphrey VF, Duck FA. Broadband measurements of the frequency dependence of attenuation coefficient and velocity in amniotic fluid, urine and human serum albumin solutions. Ultrasound Med Biol. 2005;31(10):1375–1381.
   PubMed Web of Science ®Google Scholar
• Keshavarzi A, Vaezy S, Kaczkowski PJ, et al. Attenuation coefficient and sound speed in human myometrium and uterine fibroid tumors. J Ultrasound Med. 2001;20(5):473–480.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Rabinovici J, Tempany CMC, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85(1):22–29.
   PubMed Web of Science ®Google Scholar
• Lénárd ZM, McDannold NJ, Fennessy FM, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-imaging predictors of success. Radiology. 2008;249(1):187–194.
   PubMed Web of Science ®Google Scholar
• Ueda H, Togashi K, Konishi I, et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radio Graph. 1999;19(1):S131–S145.
   Google Scholar
• Wang Y, Ren D, Wang W. The influence of oxytocin on the blood perfusion of uterine fibroids: contrast-enhanced ultrasonography evaluation. J Med Ultrasound. 2016;24(1):13–17.
   Web of Science ®Google Scholar
• Ikink ME, Voogt MJ, van den Bosch MAAJ, et al. Diffusion-weighted magnetic resonance imaging using different b-value combinations for the evaluation of treatment results after volumetric MR-guided high-intensity focused ultrasound ablation of uterine fibroids. Eur Radiol. 2014;24(9):2118–2127.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Krol P, et al. Oxytocin administration in high-intensity focused ultrasound treatment of myomata. Biomed Res Int. 2018;2018:7518026.
   PubMed Web of Science ®Google Scholar
• Otonkoski S, Sainio T, Komar G, et al. Oxytocin selectively reduces blood flow in uterine fibroids without an effect on myometrial blood flow: a dynamic contrast enhanced MRI evaluation. Int J Hyperthermia. 2020;37(1):1293–1300.
   PubMed Web of Science ®Google Scholar
• Suomi V, et al. Comprehensive feature selection for classifying the treatment outcome of high-intensity ultrasound therapy in uterine fibroids. Sci Rep. 2019;9:1–11.
   PubMed Web of Science ®Google Scholar
• Andrews S, Yuan Q, Bailey A, et al. Multiparametric MRI characterization of Funaki types of uterine fibroids considered for MR-guided high-intensity focused ultrasound (MR-HIFU) therapy. Acad Radiol. 2019;26(4):e9–e17.
   PubMedGoogle Scholar
• Celik A. Effect of imaging parameters on the accuracy of apparent diffusion coefficient and optimization strategies. Diagn Interv Radiol. 2016;22(1):101–107.
   PubMed Web of Science ®Google Scholar
• Donati OF, Chong D, Nanz D, et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology. 2014;270(2):454–463.
   PubMed Web of Science ®Google Scholar
• Ogura A, et al. Apparent diffusion coefficient value is not dependent on magnetic resonance systems and field strength under fixed imaging parameters in brain. J Comput Assist Tomogr. 2015;39:760–765.
   PubMed Web of Science ®Google Scholar
• Eghtedari M, Ma J, Fox P, et al. Effects of magnetic field strength and b value on the sensitivity and specificity of quantitative breast diffusion-weighted MRI. Quant Imaging Med Surg. 2016;6(4):374–380.
   PubMed Web of Science ®Google Scholar
• Merhemic Z, Imsirovic B, Bilalovic N, et al. Apparent diffusion coefficient reproducibility in brain tumors measured on 1.5 and 3 T clinical scanners: a pilot study. Eur J Radiol. 2018;108:249–253.
   PubMed Web of Science ®Google Scholar